MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Nutritional Parameter Changes in Parkinson’s Disease Patients Receiving Continuous Subcutaneous Infusion of Foslevodopa-Foscarbidopa

    M. Barichella, MC. Macchione, G. Lazzeri, E. Cereda, I. Ioannis, G. Pezzoli (Milano, Italy)

    Objective: This study aims to assess changes in nutritional parameters in patients with Parkinson’s disease (PD) undergoing continuous subcutaneous infusion (CSCI) of foslevodopa-foscarbidopa. Background: Device-aided…
  • 2025 International Congress

    Quantitative assessment of micrographia and bradykinesia in Parkinson’s disease

    S. Obika, J. Ortega, M. Escribano, A. Ruiz-Yanzi, C. Del Toro, E. Natera-Villalba, C. Gasca-Salas, M. Matarazzo, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Madrid, Spain)

    Objective: We aimed to evaluate if micrographia in Parkinson’s disease (PD) patients correlates with the severity of bradykinesia and whether or not micrographia is improved…
  • 2025 International Congress

    Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

    J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)

    Objective: To assess a multidisciplinary hospital day service for Parkinson’s disease and fall-related concerns, identify service gaps, and evaluate its 5-year impact. Background: The Day…
  • 2025 International Congress

    Patient engagement in Parkinson’s research: Exploring stakeholder perspectives

    J. Bek, N. Simonian, C. Rattan, A. Asis (Dublin, Ireland)

    Objective: The aim of this project was to explore patient engagement in Parkinson’s research in Canada from the perspectives of different stakeholders, and to identify…
  • 2025 International Congress

    PHIT-Brain Study Protocol: Adaptation and Evaluation of a Multifaceted Brain Health Intervention for Patients with Parkinson’s Disease and Mild Cognitive Impairment (PD-MCI)

    G. Roth, D. Gonzalez (Chicago, USA)

    Objective: The aim is to adapt a brain health program for the PD population, the Parkinson’s Health Initiative for Thinking and the Brain (PHIT Brain),…
  • 2025 International Congress

    Caregiver Burden after DBS at GPI or STN for Parkinson’s Disease

    A. Kamath, H. Branstetter, J. Summers, T. Hassell, S. Bick, N. Banerjee, K. Dhima (Nashville, USA)

    Objective: Examine the effects of GPi or STN DBS on caregiver burden for Parkinson's Disease Background: Deep Brain Stimulation (DBS) is a common treatment used…
  • 2025 International Congress

    Anti-Diabetic Medications to Fight Parkinson’s Disease and Lewy Body Dementia

    T. Chmiela, J. Dulski, Z. Parrales, Z. Wszolek, J. Wilson (Jacksonville, USA)

    Objective: To evaluate the tolerability and clinical effects of newer antidiabetic drugs in individuals with Parkinson's disease (PD) and Lewy body dementia (LBD). Background: Parkinson’s…
  • 2025 International Congress

    Reduced Falls With ND0612: Supportive Analyses From the BouNDless Phase 3 Study

    S. Isaacson, F. Stocchi, A. Ellenbogen, N. Lopes, N. Sasson, J. Pereira, O. Rascol (Boca Raton, USA)

    Objective: Explore potential reasons for the lower rates of falls with ND0612 vs immediate-release levodopa/carbidopa (IR-LD/CD) therapy reported in the BouNDless study. Background: Falls are…
  • 2025 International Congress

    The NICE-PD Trial: Cost-Effectiveness of Specialized Nursing Interventions for People with Parkinson’s Disease

    D. Radder, B. Maas, E. Zeeboer, H. Lennaerts, L. Ter Brake, E. Adang, J. Int Hout, H. Vermeulen, T. van Asseldonk, C. Delnooz, R. Hagen, M. Munneke, B. Bloem, N. de Vries (Nijmegen, Netherlands)

    Objective: We aimed to assess the cost-effectiveness of adding specialized nursing care to usual care compared with usual care alone in people with Parkinson’s disease…
  • 2025 International Congress

    Effect of Allogeneic Bone-Marrow Derived Mesenchymal Stem Cell Therapy on Quality of Life in Patients with Parkinson’s Disease

    C. Onuigbo, J. Martinez-Lemus, T. Thomas, E. Tharp, J. Suescun, C. Green, T. Ellmore, E. Rodarte Rascon, R. Ritter, M. Schiess (Houston, USA)

    Objective: To assess the impact of intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) infusions on the quality of life (QoL) of patients with…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley